NCT06507579View on ClinicalTrials.gov

Hydra Registry - UK

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

July 11, 2024

Primary Completion Date

July 11, 2026

Study Completion Date

August 1, 2026

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

Hydra transcatheter aortic valve (THV) series

The Hydra device consists of a self-expanding nitinol frame and three bovine pericardial leaflets in supra-annular position.

Trial Locations (4)

S5 7AU

RECRUITING

Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield

BT12 6BA

NOT_YET_RECRUITING

Royal Victoria Hospital, Belfast

CB2 0AY

NOT_YET_RECRUITING

Royal Papworth, Cambridge

HU16 5JQ

RECRUITING

Castle Hill Hull, Cottingham

All Listed Sponsors
collaborator

Psephos Biomedica

UNKNOWN

lead

Sahajanand Medical Technologies Limited

INDUSTRY

NCT06507579 - Hydra Registry - UK | Biotech Hunter | Biotech Hunter